Under the C-diff section on Immuron’s website it says- “Results for Immuron’s animal recurrence studies will be available this January. Positive results in the study would conclude that IMM-529 would be beneficial in treatments for all three phases of the disease, prevention, initial treatment, and recurrence, with recurrence being the largest unmet need
“
Anyone heard anything about the results because it is already February?
Under the C-diff section on Immuron’s website it says- “Results...
-
- There are more pages in this discussion • 16 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
